CHO Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 40

Employees

  • Stock Symbol
  • 6586

Stock Symbol

  • Share Price
  • $2.73
  • (As of Monday Closing)

CHO Pharma General Information

Description

CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 18F, Building F, No. 3
  • Park Street, Nangang
  • Taipei, 115-03
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
ROCO
Vertical(s)
Corporate Office
  • 18F, Building F, No. 3
  • Park Street, Nangang
  • Taipei, 115-03
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CHO Pharma Stock Performance

As of 16-Nov-2026, CHO Pharma’s stock price is $2.73. Its current market cap is $583M with 214M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.73 $2.32 $0.71 - $4.66 $583M 214M 495K -$0.04

CHO Pharma Financials Summary

As of 30-Jun-2026, CHO Pharma has a trailing 12-month revenue of $54.9K.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 824,899 121,783 257,294 383,710
Revenue 55 46 112 0
EBITDA (8,955) (9,590) (6,959) (9,438)
Net Income (8,628) (9,296) (6,613) (9,827)
Total Assets 77,294 82,267 87,620 100,431
Total Debt 230 466 879 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CHO Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CHO Pharma‘s full profile, request access.

Request a free trial

CHO Pharma Patents

CHO Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024204980-A1 Fucosidase mutants and the use thereof Pending 28-Jul-2023
EP-4509598-A1 Fucosidase mutants and the use thereof Active 28-Jul-2023
EP-4509598-B1 Fucosidase mutants and the use thereof Active 28-Jul-2023
EP-4509598-C0 Fucosidase mutants and the use thereof Active 28-Jul-2023
ES-3073626-T3 Fucosidase mutants and the use thereof Active 28-Jul-2023 C12N9/2402
To view CHO Pharma’s complete patent history, request access »

CHO Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CHO Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view CHO Pharma’s complete esg history, request access »

CHO Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Cho Pharma Usa Woburn, MA 2019

CHO Pharma FAQs

  • When was CHO Pharma founded?

    CHO Pharma was founded in 2013.

  • Where is CHO Pharma headquartered?

    CHO Pharma is headquartered in Taipei, Taiwan.

  • What is the size of CHO Pharma?

    CHO Pharma has 40 total employees.

  • What industry is CHO Pharma in?

    CHO Pharma’s primary industry is Drug Discovery.

  • Is CHO Pharma a private or public company?

    CHO Pharma is a Public company.

  • What is CHO Pharma’s stock symbol?

    The ticker symbol for CHO Pharma is 6586.

  • What is the current stock price of CHO Pharma?

    As of 16-Nov-2026 the stock price of CHO Pharma is $2.73.

  • What is the current market cap of CHO Pharma?

    The current market capitalization of CHO Pharma is $583M.

  • What is CHO Pharma’s current revenue?

    The trailing twelve month revenue for CHO Pharma is $54.9K.

  • What is CHO Pharma’s annual earnings per share (EPS)?

    CHO Pharma’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process